The pleiotrophic role of the receptor tyrosine kinase (RTK) c-MET in cellular processes and its important role for cancer progression suggest that c-MET may be a promising target for anticancer therapy [49,50,51,52]. This evidence concerns the gene NTRK1 and cancer.